Signs and symptoms – Communicable Diseases Research

Main changes in the “COVID-19 in paediatrics” clinical practice guideline

코로나19 소아과 진료지침 주요 변경사항

Article

Published on 2022-08-012022-09-11
Journal: Anales de pediatria
[Category] COVID19(2023년), SARS, 변종, 임상,

Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy

임신 중 자간전증 및 COVID-19의 내피 및 혈관 신생 프로파일의 차이 및 유사성

Article

Published on 2022-08-012022-08-31
Journal: American journal of obstetrics and gynecology
[Category] MERS, 바이오마커, 진단,

[키워드] absence activate addition Adhesion Molecule alteration Analysis Angiogenesis angiogenic factors angiopoietin Antigen Biomarker Biomarkers C5b9 Cell cell membrane cell membranes Cell signaling change changes in circulating Coagulation Coagulopathy component Concentration Control controls COVID-19 COVID-19 infection COVID-19 patients Culture demonstrated difference differential diagnosis differentiation disease disorder endothelial Endothelial cell endothelial cells endothelial damage Endothelial dysfunction evaluated exhibited expected explained expression Extracellular Extracellular matrix group growth growth factor healthy heparan sulfate hypertensive hypertensive disorders of pregnancy Immunoblots immunofluorescence in some in vitro increase in Infection Inflammation inflammatory signaling innate immune response intercellular intercellular adhesion molecule less lysate lysates Mild mitogen-activated protein kinase Necrosis neutrophil Neutrophil extracellular trap Neutrophil extracellular traps normotensive overexpression Pathways Patient Phosphorylation placental placental growth factor preeclampsia Pregnancy pregnant women Principal component principal component analysis profile profiles Protein protein kinase receptor reduced reduction reduction in SARS-CoV-2 sera severe COVID-19 severe COVID-19 patient signaling pathway significant increase significantly increased Signs and symptoms similarity soluble fms-like tyrosine kinase-1 soluble tumor necrosis factor-α receptor I Spectrum statistical analysis statistically Study design sulfate Symptom Tumor tumor necrosis tumor necrosis factor-α tyrosine variable variance vascular cell adhesion von Willebrand disease von Willebrand factor von Willebrand factor. with COVID-19 women
[DOI] 10.1016/j.ajog.2022.03.048 PMC 바로가기 [Article Type] Article

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

ISARIC-COVID-19 데이터 세트: COVID-19로 입원한 환자의 전향적이고 표준화된 글로벌 데이터 세트

Article

Published on 2022-07-302022-09-11
Journal: Scientific Data
[Category] COVID19(2023년), SARS, 임상, 치료기술, 치료법,

The Risk of Obstetrical Hemorrhage in Placenta Praevia Associated with Coronavirus Infection Antepartum or Intrapartum

코로나바이러스 감염과 관련된 근위태반의 산과 출혈 위험 분만 전 또는 분만 중

Article

Published on 2022-07-272022-09-11
Journal: Medicina
[Category] COVID19(2023년), SARS, 치료기술,

[키워드] analyzed antepartum Birth bleeding Childbirth Complication conducted COVID driven by evaluate first trimester group hemorrhage Hemostasis histological change Hospitalization hypertension identify incidence increase infected patients Infection intrapartum labor material no infection objective obstetrical bleeding occurred Patient patients Placenta placenta accreta placenta previa placenta previa. Pregnancy pregnancy-induced hypertension Prematurity presenting Result Retrospective study risk SARS-CoV-2 SARS-COV-2 infection severity significantly Signs and symptoms similarities specific treatment statistically significant difference stratified Symptoms three groups time of delivery viral disease viral infection with infection
[DOI] 10.3390/medicina58081004 PMC 바로가기 [Article Type] Article

Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection

SARS-CoV-2 감염 진단을 위한 신속한 현장 진료 항원 검사

Review

Published on 2022-07-222022-09-11
Journal: The Cochrane database of systematic reviews
[Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료제,

[키워드] 95% CI 95% confidence interval absence access Accuracy age Antigen antigen test antigen tests approach assays Asymptomatic average Bern bioRxiv brand can not carried Chain Reaction Characteristics checked CIs Cohort Compliance conducted COVID-19 COVID-19 pandemic COVID-19 testing criteria criterion Data collection database demonstrated described detect diagnosis of SARS-CoV-2 diagnostic Diagnostic accuracy diagnostic tests Effectiveness eligible epidemiological estimate Europe evaluate evaluated Evidence exposure to False positive False positives global health groups Health Organization healthcare help heterogeneity highest include independent indication Infection Interpretation investigated logistic regression models management Mass screening measure medRxiv molecular test National Open Access Other participant Participants Patient care point-of-care polymerase chain polymerase chain reaction population groups Positive predictive value positive result PPV Predictive value presence or absence Prevalence produced public health QUADAS-2 random-effect ranged Rapid rapid antigen test Rapid antigen tests Rapid diagnostic test reduce reducing reference reference standard Reference standards repeated reported Research respiratory respiratory sample resulting reverse transcription reverse transcription polymerase chain reaction RT-PCR RT-PCR testing SARS-CoV-2 SARS-COV-2 infection Schools screened screening procedure screening programmes searched second Selection sensitivities sensitivity Sensitivity and specificity Seven Signs and symptoms Source Specificities specificity study cohort Study design Symptom symptom onset symptom status symptomatic symptomatic and asymptomatic symptomatic participant symptomatic participants symptomatic people symptoms of COVID-19 test negative test result Testing to define Transmission Triage unique University of Bern variable Viral Viral load viral loads website were used WHO World Health Organization
[DOI] 10.1002/14651858.CD013705.pub3 PMC 바로가기 [Article Type] Review

Temporal trends and differences of SARS-CoV-2-specific antibody responses in symptomatic and asymptomatic subjects: a longitudinal study from Umbria in Italy

증상이 있는 대상과 무증상 대상에서 SARS-CoV-2 특이 항체 반응의 시간적 경향과 차이점: 이탈리아 Umbria의 종단 연구

Article

Published on 2022-07-182022-09-11
Journal: BMJ Open
[Category] COVID19(2023년), MERS, SARS, 진단, 치료법,

[키워드] anti-S anti-S antibody antibody Antibody Response Antibody responses Antibody titre antibody titres Asymptomatic Clinical severity clinically Cohort correlation COVID-19 Decline Diagnosis discharged Dynamics eligible first visit Follow-up follow-up study group hospital Immunity immunology Infectious diseases Italy longitudinal overtime participant Participants PCR test persistence positive Protein recruited reduced Reinfection remained SARS-CoV-2 SARS-COV-2 infection serological Serological testing significant difference significantly higher Signs and symptoms spike Spike proteins subject subjects Symptom symptomatic symptomatic and asymptomatic Temporal the median three group three groups threshold titre titres Treatment two groups U/mL Variation Virology Virology. while without symptom
[DOI] 10.1136/bmjopen-2021-056370 PMC 바로가기 [Article Type] Article

OMICRON: Virology, immunopathogenesis, and laboratory diagnosis

OMICRON: 바이러스학, 면역병리학 및 실험실 진단

Review

Published on 2022-07-012022-09-11
Journal: The journal of gene medicine
[Category] COVID19(2023년), SARS, 변종,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addressed Alpha antibody approach B.1.1.529 Beta Biology Booster vaccine Clinical sign coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 decrease Delta Diagnosis diagnostic dose Gamma Genetic Genome Health Organization Immunopathogenesis immunopathological increased risk Infection Laboratory management Mortality Mutation omicron Omicron variant pediatrics Re-infection receptor binding site respiratory virus risk severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) severity Signs and symptoms Spike protein Spread Symptoms therapeutic Transmissibility understanding Vaccine vaccine response Vaccines variant variants variants of concern Virology Virology. World Health Organization
[DOI] 10.1002/jgm.3435 PMC 바로가기 [Article Type] Review

ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2

ESCMID COVID-19 가이드라인: SARS-CoV-2에 대한 진단 테스트

Article

Published on 2022-06-012022-09-11
Journal: Clinical microbiology and infection : the official
[Category] COVID19(2023년), SARS, 진단, 치료기술,

[키워드] adaptation age antigen detection approach assessment Asymptomatic individuals Care chair Clinicians close contact Committee COVID-19 COVID-19 guideline de novo development Diagnosis diagnostic diagnostic test disease severity Evidence exposure to Guidance guidelines Health Health care healthcare Healthcare workers identify individual infected with SARS-CoV-2 Intervention involved list majority nucleic acid nucleic acid amplification once a week outcome Patient performed PICO Quality question recommendation recommendations risk SARS-CoV-2 selected severe disease Signs and symptoms Symptom systematic reviews Task Force Testing testing. was used
[DOI] 10.1016/j.cmi.2022.02.011 PMC 바로가기 [Article Type] Article

Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study

Post-COVID-19 증후군, 저등급 염증 및 염증 표지자: 단면 연구

Article

Published on 2022-06-012022-09-11
Journal: Current medical research and opinion
[Category] MERS, 바이오마커,

[키워드] acute COVID-19 acute phase affected age Ageusia analysed analysis Anosmia association available data best Biomarker Biomarkers BMI C-reactive protein collected Community community setting Comorbidities correlation COVID-19 COVID-19 case cross-sectional cross-sectional study CRP D-dimer level D-dimer levels defined develop distributions Dyspnea Elevation epidemiological data fatigue ferritin fibrinogen Fibrinogen levels Frequency highest identify increased risk Infection Inflammatory inflammatory markers Laboratory Laboratory test Lactate lactate dehydrogenase low-grade inflammation lymphocyte lymphocyte counts marker men Mild mild COVID-19. multivariable analysis multivariate multivariate analyses myalgia neutrophil neutrophil count neutrophil counts neutrophil/lymphocyte ratio NLR pathophysiological mechanism performed post-COVID syndrome prevalent reported symptom selected serum C-reactive protein Sex Sex difference Signs and symptoms smoking subject Symptom Symptoms syndrome the median variable with COVID-19 woman women
[DOI] 10.1080/03007995.2022.2042991 PMC 바로가기 [Article Type] Article

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19

1차 진료 또는 병원 외래 환자 환경에 있는 환자가 COVID-19에 감염되었는지 확인하기 위한 징후 및 증상

Review

Published on 2022-05-202022-09-11
Journal: The Cochrane database of systematic reviews
[Category] COVID19(2023년), SARS, 치료기술, 치료제,

[키워드] 95% CI absence Abstract Accuracy addition Adults age Ageusia Analysis Anosmia applicability artificial intelligence assessment assessments Bern Chain Reaction characteristic checked children clinically clinically suspected clinics Cohort Combination combinations condition Consequences Contact Control coryza cough COVID-19 COVID-19 disease COVID-19 illness COVID-19 pneumonia COVID-19 testing criteria criterion Data collection database dependent on detection rate determine determined by diagnostic Diagnostic accuracy diagnostic test diagnostic tests diagnostic value disease Dyspnoea eligibility eligible emergency department enrolled Evidence excluded fatigue Fever FIVE Gender Health Service Health services help heterogeneity high risk hospital identify increase individual individual symptom Infection Infectious disease information initial investigated life-threatening likelihood ratio Local loss of sense of smell majority mechanism median Meta-analysis Mild Mild COVID-19 disease moderate MOST multivariable no symptom no symptoms nursing homes Older olfactory on children Outpatient outpatients overlapping pair parameter participant Participants Patient PCR Pneumonia polymerase chain polymerase chain reaction positive Presence presenting primary care Probability Prognosis Prospective Study QUADAS-2 random-effect reached receiver operating characteristic recruited reference standard Reference standards referred to reported Repository resolved Result reverse transcription reverse transcription polymerase chain reaction risk of bia ROC RT-PCR Sample size SARS-COV-2 infection selected Selection sense sense of smell sensitivity Sensitivity and specificity SIGN Signs and symptoms sore sore throat specific symptom Specificities specificity Support Symptom Symptoms Taste the disease the epidemic Travel treated University of Bern upper respiratory symptom upper respiratory symptoms were measured with COVID-19
[DOI] 10.1002/14651858.CD013665.pub3 PMC 바로가기 [Article Type] Review